newsfilter.io

Suzanne Topalian

Showing 1–2 of 2 transcripts.

  1. Milken Institute1h 0m

    Humankind vs. Cancer: The Scorecard

    Jonathan Simons, Chris Boshoff, André Choulika, Carlo Greco, Nils Lonberg, Richard Paulson, Suzanne Topalian

    Leading oncologists and industry executives convened to address the global burden of nine million annual cancer deaths by highlighting transformative breakthroughs in CAR T-cell therapy, immune checkpoint inhibitors, and precision medicine. Panelists emphasized that reducing mortality rates requires harmonizing clinical trial consent rules, shifting from empirical chemotherapy to rational drug combinations, and leveraging advanced ex vivo models to accelerate development. The consensus call to action urges a unified global strategy prioritizing early detection, patient access to novel innovations, and the removal of intellectual property barriers to eliminate the human and economic costs of cancer.

  2. Milken Institute1h 1m

    Mobilizing the Immune System in the Battle Against Cancer

    Arie Belldegrun, Michael Giordano, Jeff Rowbottom, Suzanne Topalian, Louise Perkins

    Hosted by the Melanoma Research Alliance, the "Mobilizing the Immune System in the Battle Against Cancer" panel examines the critical transition from traditional chemotherapy to innovative immunotherapies that are driving unprecedented survival rates for melanoma and other malignancies. Experts detail how genetic engineering and checkpoint inhibitors have enabled durable remissions for late-stage patients while highlighting the urgent need for new regulatory frameworks and increased nonprofit funding to accelerate the development of super-personalized combination treatments. The discussion underscores a projected five-year transformation in oncology, emphasizing that converging scientific breakthroughs and global stakeholder collaboration are essential to address rising cancer mortality and realize a potential cure for previously resistant diseases.